BFRGW

Bullfrog AI Holdings, Inc.

0.2975

+0.0623+26.49%

Opening15:38 03/31 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.2642/0.2352

TODAY RANGE0.2642-0.3700

VOL154.80K

MARKET CAP--

52 WEEK RANGE0.1000-0.8537

AVG VOL (3M)19.17K

% TURNOVER0%

TURNOVER--

P/E (TTM)-0.4733

% RANGE44.98%

EPS(TTM)-0.6286

P/E(FORWARD)--

P/B1.590

BVPS0.1871

DIVIDEND--

P/S29.17

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP--

SHARES OUTSTANDING--

NEXT EARNINGS--

FREE FLOAT--

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Reuters·1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar
Reuters·1d ago
BullFrog AI signs deal with top-5 pharma to identify MDD drug target
Reuters·1d ago
BULLFROG AI ANNOUNCES COMMERCIAL AGREEMENT WITH TOP 5 GLOBAL PHARMACEUTICAL COMPANY TO IDENTIFY AND PRIORITIZE THERAPEUTIC TARGET IN MAJOR DEPRESSIVE DISORDER
Reuters·6d ago
BullFrog AI hosts bfARENAS webinar with Xtalks Life Sciences; bfARENAS decision engine debuts
Reuters·03/11 12:00
BullFrog AI to host webinar on new precision AI decision-support capability
Reuters·02/23 11:02
Nasdaq Warns BullFrog AI Faces Delisting Over Equity Rule Breach
Reuters·02/17 21:33
BullFrog AI Receives Nasdaq Notice for Bid Price Noncompliance
Reuters·01/26 21:23
BullFrog AI Holdings Showcases AI-Driven Drug Discovery Platform in New Presentation
Reuters·01/06 12:30
BullFrog AI Platform Triples Survival Rates in Pancreatic Cancer Patient Subgroups
Reuters·12/30/2025 22:01
BullFrog AI Holdings Inc. Publishes 2025 Shareholder Letter
Reuters·12/30/2025 13:00
BullFrog AI Holdings Highlights 2025 Progress and Outlines 2026 Priorities
Reuters·11/18/2025 14:19
BullFrog AI Unveils Whitepaper Showcasing AI Platform for Drug Discovery
Reuters·10/10/2025 21:25
BULLFROG AI HOLDINGS FILES PROSPECTUS RELATES TO RESALE, FROM TIME TO TIME, OF UP TO 5 MLN SHARES BY LINCOLN PARK CAPITAL FUND LLC
Reuters·10/09/2025 20:16
BullFrog AI Holdings Inc Receives Nasdaq Notice for Noncompliance with Stockholder Equity Requirement Faces Possible Delisting
Reuters·09/30/2025 12:00
BULLFROG AI EXPANDS SALES AND MARKETING TEAM TO ACCELERATE COMMERCIAL ADOPTION OF CLINICAL TRIAL OPTIMIZATION SOLUTIONS AND BFPREP™ MODULE

Same Industry

Name/Symbol

Change%

Price

BFRGW

Regeneron Pharmaceuticals

REGN

+1.47%

748.57

GRDX

BIONTECH

BNTX

-0.50%

85.25

UTHR

Vertex Pharmaceuticals Inc

VRTX

-4.56%

433.07

Siga Technologie

SIGA

+6.85%

5.30

Moderna

MRNA

-2.68%

48.23

CRL

Medpace Holdings

MEDP

-3.30%

451.20

TLPH

ICON PLC

ICLR

+3.93%

106.10

China Biologic

CBPO

0.00%

119.99

IQV

MOLN

ARCT

Gilead Sciences Inc

GILD

+1.36%

138.20

PRAH

Incyte Corp

INCY

-2.12%

90.30

Aptevo Therapeutics Inc

APVO

-5.32%

4.270

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.